Screening Commercial Tea for Rapid Inactivation of Infectious SARS-CoV-2 in Saliva
- 31 January 2024
- journal article
- research article
- Published by Springer Nature in Food and Environmental Virology
- Vol. 16 (2) , 159-170
Abstract
SARS-CoV-2 infects the oral mucosa and is shed in salivary fluids. Traditionally, tea has been used by various cultures to treat respiratory ailments. The objective of this study was to identify commercially available teas that can rapidly inactivate infectious SARS-CoV-2 in saliva. Initially, tea (n = 24) was prepared as 40 mg/mL infusions and incubated with SARS-CoV-2 resuspended in water, for 5 min at 37 °C. Then, five teas that showed >3 log reduction in virus infectivity were further investigated at 40 and 10 mg/mL infusions for 60 and 10 s contact time with SARS-CoV-2 resuspended in saliva. Tea polyphenols were measured using the Folin-Ciocalteu assay. SARS-CoV-2 infectivity was quantified on Vero-E6 cell line using TCID50 assay. At 10 mg/mL infusion, black tea showed the highest reduction (3 log, i.e., 99.9%) of infectious SARS-CoV-2 within 10 s. Green, mint medley, eucalyptus-mint, and raspberry zinger teas showed similar inactivation of SARS-CoV-2 (1.5–2 log, i.e., 96–99% reduction). At 40 mg/mL infusions, all five teas showed >3 log reduction in virus infectivity within 10 s. Tea polyphenol but not pH was significantly correlated to virus reduction. Time-of-addition assay revealed that the five teas displayed preventive effects (0.5–1 log, i.e., 68–90% reduction) against SARS-CoV-2 infection of Vero-E6 cells as well as during post-virus infection (1.2–1.9 log, i.e., 94–98%). However, the highest inhibitory effect was observed when the teas were added at the time of virus infection (2–3 log, i.e., 99–99.9%). Our results provide insights into a rapid at-home intervention (tea drinking or gargling) to reduce infectious SARS-CoV-2 load in the oral cavity which might also mitigate infection of the oral mucosa.Keywords
Funding Information
- University of Georgia (Startup Fund)
This publication has 35 references indexed in Scilit:
- Multi-Organ Involvement in COVID-19: Beyond Pulmonary ManifestationsJournal of Clinical Medicine, 2021
- Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infectionProceedings of the National Academy of Sciences, 2021
- Modeling the load of SARS-CoV-2 virus in human expelled particles during coughing and speakingPLOS ONE, 2020
- Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infectionInternational Journal of Infectious Diseases, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Mechanism of Human Influenza Virus RNA Persistence and Virion Survival in Feces: Mucus Protects Virions From Acid and Digestive JuicesThe Journal of Infectious Diseases, 2017
- Postharvest Survival of Porcine Sapovirus, a Human Norovirus Surrogate, on Phytopathogen-Infected Leafy GreensJournal of Food Protection, 2015
- Gargling with Tea Catechin Extracts for the Prevention of Influenza Infection in Elderly Nursing Home Residents: A Prospective Clinical StudyThe Journal of Alternative and Complementary Medicine, 2006
- Processing Green Tea Extracts to Make a Beverage Ingredient2003
- Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzymeFEBS Letters, 2002